Detalles de la búsqueda
1.
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552315
2.
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.
Rheumatology (Oxford)
; 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243722
3.
Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2.
J Allergy Clin Immunol
; 152(3): 771-782, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37150360
4.
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.
Ann Rheum Dis
; 82(1): 154-160, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961761
5.
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 59(11): 3505-3514, 2020 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32829413
6.
Comparative analysis of the etanercept efficacy in children with juvenile idiopathic arthritis under the age of 4 years and children of older age groups using the propensity score matching method.
Mod Rheumatol
; 29(5): 848-855, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30149747
7.
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.
Ann Rheum Dis
; 77(1): 21-29, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28507219
8.
The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Rheumatol Int
; 38(Suppl 1): 339-346, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29637369
9.
Man with Stones Emerging from Abdomen.
Ann Emerg Med
; 78(5): e81-e82, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688449
10.
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Ann Rheum Dis
; 74(6): 1110-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24834925
11.
Defining criteria for disease activity states in systemic juvenile idiopathic arthritis based on the systemic Juvenile Arthritis Disease Activity Score.
Arthritis Rheumatol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682570
12.
Juvenile idiopathic arthritis with systemic onset with inflammatory bone lesions: two case reports of patients successfully treated with canakinumab and experience gained from literature.
Front Pediatr
; 11: 1163483, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37325364
13.
Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data.
Front Pediatr
; 11: 1114207, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36911042
14.
Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study.
Front Med (Lausanne)
; 10: 1257045, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38034538
15.
Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort.
J Scleroderma Relat Disord
; 8(2): 120-130, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287945
16.
Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry.
Pediatr Rheumatol Online J
; 20(1): 103, 2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401230
17.
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.
RMD Open
; 8(1)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35256534
18.
Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis.
Arthritis Care Res (Hoboken)
; 74(3): 364-370, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33141441
19.
Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort.
Arthritis Care Res (Hoboken)
; 74(10): 1575-1584, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33787070
20.
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial.
Pediatr Rheumatol Online J
; 19(1): 5, 2021 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407590